Group One Trading
HRTX icon

Group One Trading’s Heron Therapeutics HRTX Stock Holding History

Group One Trading’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2K Sell
37,947
-48,862
-56% -$39.2K ﹤0.01% 6141
2026
Q1 		$69.5K Sell
86,809
-58,358
-40% -$67.6K ﹤0.01% 5015
2025
Q4 		$189K Buy
+145,167
New +$179K ﹤0.01% 4422
2024
Q3 		– Sell
-54,252
Closed -$130K – 6924
2024
Q2 		$190K Buy
+54,252
New +$167K ﹤0.01% 3434
2023
Q3 		– Sell
-7,959
Closed -$11.3K – 7913
2023
Q2 		$9.23K Sell
7,959
-1,276
-14% -$2.28K ﹤0.01% 6437
2023
Q1 		$13.9K Buy
9,235
+4,838
+110% +$12.1K ﹤0.01% 5756
2022
Q4 		$11K Buy
4,397
+2,236
+103% +$7.2K ﹤0.01% 5986
2022
Q3 		$9K Sell
2,161
-8,946
-81% -$35K ﹤0.01% 6555
2022
Q2 		$31K Sell
11,107
-8,325
-43% -$33.4K ﹤0.01% 5953
2022
Q1 		$111K Buy
19,432
+10,055
+107% +$73.6K ﹤0.01% 5393
2021
Q4 		$86K Buy
+9,377
New +$95.7K ﹤0.01% 5861
2021
Q3 		– Sell
-7,721
Closed -$94K – 8420
2021
Q2 		$120K Buy
+7,721
New +$123K ﹤0.01% 5775
2020
Q4 		– Sell
-7,600
Closed -$132K – 6705
2020
Q3 		$113K Sell
7,600
-8,243
-52% -$129K ﹤0.01% 4112
2020
Q2 		$233K Buy
15,843
+12,472
+370% +$205K ﹤0.01% 3259
2020
Q1 		$40K Sell
3,371
-7,908
-70% -$149K ﹤0.01% 3857
2019
Q4 		$265K Sell
11,279
-1,954
-15% -$43.2K ﹤0.01% 2958
2019
Q3 		$245K Buy
+13,233
New +$244K ﹤0.01% 2938
2019
Q2 		– Sell
-3,220
Closed -$64.3K – 5122
2019
Q1 		$79K Sell
3,220
-361
-10% -$9.45K ﹤0.01% 3329
2018
Q4 		$93K Sell
3,581
-4,479
-56% -$123K ﹤0.01% 3207
2018
Q3 		$255K Buy
8,060
+1,296
+19% +$48.3K ﹤0.01% 2840
2018
Q2 		$263K Sell
6,764
-21,300
-76% -$678K ﹤0.01% 2834
2018
Q1 		$775K Sell
28,064
-30,210
-52% -$685K 0.01% 1703
2017
Q4 		$1.05M Buy
58,274
+33,218
+133% +$542K 0.01% 1658
2017
Q3 		$405K Sell
25,056
-6,103
-20% -$95.7K ﹤0.01% 2243
2017
Q2 		$432K Buy
+31,159
New +$451K ﹤0.01% 2078
2016
Q3 		– Sell
-37,776
Closed -$701K – 4689
2016
Q2 		$682K Buy
37,776
+22,865
+153% +$446K 0.01% 1510
2016
Q1 		$283K Sell
14,911
-543
-4% -$10.7K ﹤0.01% 2092
2015
Q4 		$413K Sell
15,454
-236,497
-94% -$6.32M ﹤0.01% 1974
2015
Q3 		$6.15M Buy
251,951
+203,361
+419% +$6.78M 0.09% 280
2015
Q2 		$1.51M Buy
+48,590
New +$914K 0.02% 921
2015
Q1 		– Sell
-13,347
Closed -$150K – 4936
2014
Q4 		$134K Buy
13,347
+12,447
+1,383% +$102K ﹤0.01% 2617
2014
Q3 		$8K Buy
900
+700
+350% +$6.52K ﹤0.01% 4560
2014
Q2 		$2K Buy
+200
New +$2.39K ﹤0.01% 5003

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Group One Trading's HRTX Position: Q2 2026 in Review

Group One Trading reduced its Heron Therapeutics (HRTX) stake by 56% in Q2 2026, selling an estimated $39.2K and leaving 37,947 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6141.

Group One Trading first reported a position in HRTX in Q2 2014 and has held it in 33 quarters since. The position peaked at $6.15M in Q3 2015. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Group One Trading held 37,947 shares of Heron Therapeutics worth $16.2K as of Q2 2026.
  • Group One Trading sold 48,862 Heron Therapeutics shares in Q2 2026, an estimated $39.2K.
  • Heron Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6141 holding.
  • Group One Trading first reported a position in Heron Therapeutics in Q2 2014 and has held it in 33 quarters since.
  • Group One Trading's Heron Therapeutics position peaked at $6.15M in Q3 2015.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.